Madrigal Pharmaceuticals
MDGL
MDGL
84 hedge funds and large institutions have $146M invested in Madrigal Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 38 increasing their positions, 26 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
42% less call options, than puts
Call options by funds: $786K | Put options by funds: $1.35M
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
Holders
84
Holding in Top 10
1
Calls
$786K
Puts
$1.35M
Top Buyers
| 1 | +$1.31M | |
| 2 | +$1.1M | |
| 3 | +$985K | |
| 4 |
Morgan Stanley
New York
|
+$861K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$770K |
Top Sellers
| 1 | -$2.71M | |
| 2 | -$1.03M | |
| 3 | -$874K | |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$737K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$447K |